Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
暂无分享,去创建一个
Y. Kakeji | G. Takiguchi | M. Yamamoto | S. Kanaji | Tetsuo Nakamura | Satoshi Suzuki | T. Itoh | Y. Otowa | T. Imanishi | Ken-ichi Tanaka | Ayako Tomono